Leptospirosis

Revision as of 04:40, 4 January 2015 by Arsmd (talk | contribs)

Background

  • Spirochete: Leptospira interrogans
  • Human exposure from animal urine, contaminated water/soil, or infected animal tissue.[1]
  • Portal from break in skin, mucousa, or conjunctiva
  • Average incubation of 10 days
  • Also described following hiking, trekking, and following triathlon competitions[2]
Conjunctival suffusion

Clinical Manifestations

  • Acute phase lasts up to 1 week
    • Mild illness to abrupt high fever, chills, intense headache, and severe myalgias (75-100% of pts)
  • Conjunctival Suffusion (redness without exudates) characteristic but not common
  • Meningitis, uveitis, transminitis, proteinuria, hematuria
  • Weil syndrome -severe manifestation with jaundice and renal failure, pulmonary hemorrhage, ARDS, myocarditis, and rhabdomyolysis (52% Mortality)
    • 10% of patients
    • caused by circulating antibodies

Laboratory findings

  1. Confirm by serology
  2. Culture
  3. Hypokalemia/Hyponatremia
  4. Thrombocytopenia
  5. Sterile pyuria
  6. Elevated CK
  7. CSF with elevated wbcs and protein with normal glucose

Differential Diagnosis

Fever in traveler

Treatment[3]

PCN

  • Penicillin G 100000U/ kg/ dose IV every 6 hours x 7days

OR

  1. >8yrs: Doxycycline 4mg/kg/dose oral every 12 hours x 7 days
  2. <8yrs: Ampicillin 75-100mg/kg/dose oral every 6 hours x 7days
  3. <8yrs: Amoxicillin 50mg/kg/dose oral 6- 8 hours x 7days

Alternatives:

  1. Ceftriaxone, Cefotaxime[4]

Source

  • Palaniappan RU, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007;20(3):284-92
  1. Radl C. et al. Outbreak of leptospirosis among triathlon participants in Langau, Austria, 2010. Wien Klin Wochenschr. Dec 2011;123(23-24):751-5
  2. CDC. Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons--Illinois and Wisconsin, 1998. MMWR Morb Mortal Wkly Rep. 1998;47(32):673-6
  3. [http://www.moh.gov.my/images/gallery/Garispanduan/GL_Leptospirosis%202011.pdf Ministry of Health Malaysia 2011 Recommendations
  4. Inada R, Ido Y, Hoki R. The etiology, mode of infection, and specific therapy of Weil's disease (spirochaetosis icterohaemorrhagica. J Exper Med. 1916;23:377-402.

See Also